Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)Daniel Betticher, David C. Linch, Martin J.S. Dyer et al.|Annals of Oncology|2006Cited by 42
Sequential high-dose chemotherapy (SHDC) with autologous stem cell transplantation (ASCT) vs standard CHOP regimen for pts with untreated aggressive NHL. Result of the mistral trial from the Swiss Group for Clinical Cancer Research (SAKK)Daniel Betticher, Susanne Cina, DC Linch et al.|UCL Discovery (University College London)|2005Cited by 1